View Financial HealthMCON Rasayan India 배당 및 자사주 매입배당 기준 점검 0/6MCON Rasayan India 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-0.02%자사주 매입 수익률총 주주 수익률-0.02%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • May 29Full year 2026 earnings released: EPS: ₹4.15 (vs ₹3.40 in FY 2025)Full year 2026 results: EPS: ₹4.15 (up from ₹3.40 in FY 2025). Revenue: ₹653.7m (up 29% from FY 2025). Net income: ₹30.4m (up 34% from FY 2025). Profit margin: 4.7% (up from 4.5% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹41.00, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 59% over the past three years.공시 • May 20MCON Rasayan India Limited to Report Second Half, 2026 Results on May 27, 2026MCON Rasayan India Limited announced that they will report second half, 2026 results on May 27, 2026New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.9x net interest cover). High level of non-cash earnings (31% accrual ratio). Market cap is less than US$10m (₹410.8m market cap, or US$4.32m). Minor Risk Share price has been volatile over the past 3 months (8.7% average weekly change).Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹56.05, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 29% over the past three years.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹45.70, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.분석 기사 • Feb 13MCON Rasayan India (NSE:MCON) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • Dec 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹72.60, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 65% over the past year.공시 • Nov 07MCON Rasayan India Limited to Report First Half, 2026 Results on Nov 12, 2025MCON Rasayan India Limited announced that they will report first half, 2026 results on Nov 12, 2025Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹63.50, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.분석 기사 • Sep 26Slammed 28% MCON Rasayan India Limited (NSE:MCON) Screens Well Here But There Might Be A CatchTo the annoyance of some shareholders, MCON Rasayan India Limited ( NSE:MCON ) shares are down a considerable 28% in...Valuation Update With 7 Day Price Move • Sep 25Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹61.65, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 61% over the past year.분석 기사 • Sep 18Here's Why MCON Rasayan India (NSE:MCON) Has A Meaningful Debt BurdenThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...공시 • Sep 01MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹77.65, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.분석 기사 • Aug 05Market Cool On MCON Rasayan India Limited's (NSE:MCON) Earnings Pushing Shares 25% LowerUnfortunately for some shareholders, the MCON Rasayan India Limited ( NSE:MCON ) share price has dived 25% in the last...New Risk • Jun 03New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹834.4m (US$9.75m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). High level of non-cash earnings (45% accrual ratio). Market cap is less than US$10m (₹834.4m market cap, or US$9.75m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding).New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹924.5m market cap, or US$10.8m).Valuation Update With 7 Day Price Move • May 30Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹126, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 16% over the past year.New Risk • May 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹1.02b market cap, or US$12.0m).Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹153, the stock trades at a trailing P/E ratio of 46.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 20% over the past year.Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹145, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 17% over the past year.Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.분석 기사 • Feb 07Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...분석 기사 • Dec 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹191, the stock trades at a trailing P/E ratio of 49.9x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 22% over the past year.Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹158, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 9.2% over the past year.New Risk • Nov 21New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$13.1m).New Risk • Nov 06New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹421m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks High level of debt (97% net debt to equity). Revenue is less than US$5m (₹421m revenue, or US$5.0m). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹181, the stock trades at a trailing P/E ratio of 51x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 24% over the past year.분석 기사 • Oct 12The Price Is Right For MCON Rasayan India Limited (NSE:MCON) Even After Diving 27%The MCON Rasayan India Limited ( NSE:MCON ) share price has fared very poorly over the last month, falling by a...분석 기사 • Sep 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Reported Earnings • Aug 23Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹421.3m (up 36% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.공시 • Aug 20MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024, at 11:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹182, the stock trades at a trailing P/E ratio of 51.3x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 72% over the past year.분석 기사 • Jun 23Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Jun 14New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (30% accrual ratio). Minor Risk Market cap is less than US$100m (₹904.6m market cap, or US$10.8m).Reported Earnings • May 27Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹425.4m (up 37% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.분석 기사 • May 26MCON Rasayan India Limited (NSE:MCON) Not Lagging Market On Growth Or PricingMCON Rasayan India Limited's ( NSE:MCON ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...Valuation Update With 7 Day Price Move • May 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹106, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 14% over the past year.New Risk • May 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹811.6m market cap, or US$9.71m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹155, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 30x in the Chemicals industry in India.New Risk • Feb 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹827.4m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹827.4m market cap, or US$9.96m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹162, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 29x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹127, the stock trades at a trailing P/E ratio of 70.2x. Average trailing P/E is 27x in the Chemicals industry in India.Reported Earnings • Sep 13Full year 2023 earnings released: EPS: ₹2.63 (vs ₹1.29 in FY 2022)Full year 2023 results: EPS: ₹2.63 (up from ₹1.29 in FY 2022). Revenue: ₹310.5m (up 62% from FY 2022). Net income: ₹11.4m (up 129% from FY 2022). Profit margin: 3.7% (up from 2.6% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Sep 12Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹138, the stock trades at a trailing P/E ratio of 76.5x. Average trailing P/E is 28x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Jul 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹126, the stock trades at a trailing P/E ratio of 70.1x. Average trailing P/E is 23x in the Chemicals industry in India.분석 기사 • Jul 08Getting In Cheap On MCON Rasayan India Limited (NSE:MCON) Might Be DifficultWith a price-to-earnings (or "P/E") ratio of 66.8x MCON Rasayan India Limited ( NSE:MCON ) may be sending very bearish...Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹116, the stock trades at a trailing P/E ratio of 64.3x. Average trailing P/E is 21x in the Chemicals industry in India.Reported Earnings • May 31Full year 2023 earnings releasedFull year 2023 results: Revenue: ₹310.6m (up 62% from FY 2022). Net income: ₹11.4m (up 156% from FY 2022). Profit margin: 3.7% (up from 2.3% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹54.95, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 19x in the Chemicals industry in India.Board Change • Mar 21High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 MCON 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: MCON 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장MCON Rasayan India 배당 수익률 vs 시장MCON의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (MCON)n/a시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Chemicals)0.8%분석가 예측 (MCON) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 MCON 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 MCON 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 MCON 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: MCON 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/07 08:58종가2026/06/05 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MCON Rasayan India Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 29Full year 2026 earnings released: EPS: ₹4.15 (vs ₹3.40 in FY 2025)Full year 2026 results: EPS: ₹4.15 (up from ₹3.40 in FY 2025). Revenue: ₹653.7m (up 29% from FY 2025). Net income: ₹30.4m (up 34% from FY 2025). Profit margin: 4.7% (up from 4.5% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹41.00, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 59% over the past three years.
공시 • May 20MCON Rasayan India Limited to Report Second Half, 2026 Results on May 27, 2026MCON Rasayan India Limited announced that they will report second half, 2026 results on May 27, 2026
New Risk • May 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.9x net interest cover). High level of non-cash earnings (31% accrual ratio). Market cap is less than US$10m (₹410.8m market cap, or US$4.32m). Minor Risk Share price has been volatile over the past 3 months (8.7% average weekly change).
Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹56.05, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 29% over the past three years.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹45.70, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.
분석 기사 • Feb 13MCON Rasayan India (NSE:MCON) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • Dec 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹72.60, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 65% over the past year.
공시 • Nov 07MCON Rasayan India Limited to Report First Half, 2026 Results on Nov 12, 2025MCON Rasayan India Limited announced that they will report first half, 2026 results on Nov 12, 2025
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹63.50, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.
분석 기사 • Sep 26Slammed 28% MCON Rasayan India Limited (NSE:MCON) Screens Well Here But There Might Be A CatchTo the annoyance of some shareholders, MCON Rasayan India Limited ( NSE:MCON ) shares are down a considerable 28% in...
Valuation Update With 7 Day Price Move • Sep 25Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹61.65, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 61% over the past year.
분석 기사 • Sep 18Here's Why MCON Rasayan India (NSE:MCON) Has A Meaningful Debt BurdenThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
공시 • Sep 01MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025MCON Rasayan India Limited, Annual General Meeting, Sep 25, 2025, at 11:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹77.65, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 56% over the past year.
분석 기사 • Aug 05Market Cool On MCON Rasayan India Limited's (NSE:MCON) Earnings Pushing Shares 25% LowerUnfortunately for some shareholders, the MCON Rasayan India Limited ( NSE:MCON ) share price has dived 25% in the last...
New Risk • Jun 03New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹834.4m (US$9.75m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). High level of non-cash earnings (45% accrual ratio). Market cap is less than US$10m (₹834.4m market cap, or US$9.75m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding).
New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹924.5m market cap, or US$10.8m).
Valuation Update With 7 Day Price Move • May 30Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹126, the stock trades at a trailing P/E ratio of 38.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 16% over the past year.
New Risk • May 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₹1.02b market cap, or US$12.0m).
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹153, the stock trades at a trailing P/E ratio of 46.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 20% over the past year.
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹145, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 17% over the past year.
Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
분석 기사 • Feb 07Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
분석 기사 • Dec 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹191, the stock trades at a trailing P/E ratio of 49.9x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 22% over the past year.
Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹158, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 9.2% over the past year.
New Risk • Nov 21New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$13.1m).
New Risk • Nov 06New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹421m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks High level of debt (97% net debt to equity). Revenue is less than US$5m (₹421m revenue, or US$5.0m). Market cap is less than US$100m (₹1.20b market cap, or US$14.2m).
Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹181, the stock trades at a trailing P/E ratio of 51x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 24% over the past year.
분석 기사 • Oct 12The Price Is Right For MCON Rasayan India Limited (NSE:MCON) Even After Diving 27%The MCON Rasayan India Limited ( NSE:MCON ) share price has fared very poorly over the last month, falling by a...
분석 기사 • Sep 25Here's Why We Think MCON Rasayan India (NSE:MCON) Is Well Worth WatchingIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Reported Earnings • Aug 23Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹421.3m (up 36% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
공시 • Aug 20MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024MCON Rasayan India Limited, Annual General Meeting, Sep 12, 2024, at 11:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹182, the stock trades at a trailing P/E ratio of 51.3x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 72% over the past year.
분석 기사 • Jun 23Is MCON Rasayan India (NSE:MCON) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Jun 14New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (30% accrual ratio). Minor Risk Market cap is less than US$100m (₹904.6m market cap, or US$10.8m).
Reported Earnings • May 27Full year 2024 earnings released: EPS: ₹3.56 (vs ₹2.63 in FY 2023)Full year 2024 results: EPS: ₹3.56 (up from ₹2.63 in FY 2023). Revenue: ₹425.4m (up 37% from FY 2023). Net income: ₹22.4m (up 97% from FY 2023). Profit margin: 5.3% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue.
분석 기사 • May 26MCON Rasayan India Limited (NSE:MCON) Not Lagging Market On Growth Or PricingMCON Rasayan India Limited's ( NSE:MCON ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...
Valuation Update With 7 Day Price Move • May 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹106, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 14% over the past year.
New Risk • May 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹811.6m market cap, or US$9.71m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹155, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 30x in the Chemicals industry in India.
New Risk • Feb 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹827.4m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (₹827.4m market cap, or US$9.96m). Minor Risk Revenue is less than US$5m (₹353m revenue, or US$4.2m).
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹162, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 29x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹127, the stock trades at a trailing P/E ratio of 70.2x. Average trailing P/E is 27x in the Chemicals industry in India.
Reported Earnings • Sep 13Full year 2023 earnings released: EPS: ₹2.63 (vs ₹1.29 in FY 2022)Full year 2023 results: EPS: ₹2.63 (up from ₹1.29 in FY 2022). Revenue: ₹310.5m (up 62% from FY 2022). Net income: ₹11.4m (up 129% from FY 2022). Profit margin: 3.7% (up from 2.6% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Sep 12Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹138, the stock trades at a trailing P/E ratio of 76.5x. Average trailing P/E is 28x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Jul 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹126, the stock trades at a trailing P/E ratio of 70.1x. Average trailing P/E is 23x in the Chemicals industry in India.
분석 기사 • Jul 08Getting In Cheap On MCON Rasayan India Limited (NSE:MCON) Might Be DifficultWith a price-to-earnings (or "P/E") ratio of 66.8x MCON Rasayan India Limited ( NSE:MCON ) may be sending very bearish...
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹116, the stock trades at a trailing P/E ratio of 64.3x. Average trailing P/E is 21x in the Chemicals industry in India.
Reported Earnings • May 31Full year 2023 earnings releasedFull year 2023 results: Revenue: ₹310.6m (up 62% from FY 2022). Net income: ₹11.4m (up 156% from FY 2022). Profit margin: 3.7% (up from 2.3% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹54.95, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 19x in the Chemicals industry in India.
Board Change • Mar 21High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Tapas Majumdar was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.